Drug Profile
Dendritic cell vaccine head and neck cancer - SOTIO
Alternative Names: DCVAC/HNCaLatest Information Update: 28 Jul 2018
Price :
$50
*
At a glance
- Originator SOTIO
- Class Cancer vaccines; Cell therapies; Dendritic cell vaccines; Immunotherapies
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Head and neck cancer
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for clinical-Phase-Unknown development in Head-and-neck-cancer in European Union (SC)
- 01 Jan 2014 Clinical trials in Head and neck cancer in European Union (SC)